Goals

  • To foster multidisciplinary collaboration to develop and validate tumor-agnostic precision biomarkers and translate patient-focused research into clinical practice 
  • To promote tumor-agnostic biomarker implementation through cross-departmental collaboration, enabling clinical translation across cancer types via shared expertise and infrastructure 
  • To improve survival and quality of life for patients with solid cancers by enhancing personalized treatment allocation and ensuring timely access to the most effective therapies 
  • To ensure the sustainability and affordability of precision medicine by integrating health-economic evaluations into the program 


Research Research programs Precision medicine in patients with solid cancer:

Our mission

We aim to enhance outcomes for patients with solid cancer, particularly those treated with targeted and immuno-therapies, by advancing innovative technologies such as molecular diagnostics, AI and integrative data analysis.


Goals

See some of the most important goals for this research program.

read more

Research groups contributing to this research program

Spokesperson(s) for this research program


Spokesperson

dr. Niven Mehra

contact form